This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Dec;152(6):1088-9.

doi: 10.1016/j.surg.2012.08.059.

Anaplastic thyroid cancer: rare, fatal, and neglected

Electron Kebebew¹

Affiliations

PMID: 23158179
DOI: 10.1016/j.surg.2012.08.059

Comment

Anaplastic thyroid cancer: rare, fatal, and neglected

Electron Kebebew. Surgery. 2012 Dec.

. 2012 Dec;152(6):1088-9.

doi: 10.1016/j.surg.2012.08.059.

Author

Electron Kebebew¹

Affiliation

¹ Endocrine Oncology Branch, National Cancer Institute, Bethesda, MD 20892., USA. kebebewe@mail.nih.gov

PMID: 23158179
DOI: 10.1016/j.surg.2012.08.059

No abstract available

PubMed Disclaimer

Comment on

Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer.
Sosa JA, Balkissoon J, Lu SP, Langecker P, Elisei R, Jarzab B, Bal CS, Marur S, Gramza A, Ondrey F. Sosa JA, et al. Surgery. 2012 Dec;152(6):1078-87. doi: 10.1016/j.surg.2012.08.036. Surgery. 2012. PMID: 23158178 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information